Yonghe Medical Group Co., Ltd. (2279) detailed a newly adopted Board Diversity Policy, focusing on the benefits of having directors with varied skills, regional and industry experience, backgrounds, gender, and other qualities. According to the announcement, board appointments adhere to merit-based selection, with consideration of factors such as professional experience, educational background, independence, age, and gender.

The policy highlights an annual review process by the Nomination Committee, which evaluates the structure, size, and composition of the board and makes suggestions in line with the company’s strategy. The final decision on any board changes will be based on each individual’s comprehensive contribution. It is explicitly stated that the board will not consist of directors of a single gender.

The Nomination Committee will monitor and report on the board’s composition and oversee policy implementation. If specific measurable diversity objectives are established, the progress toward meeting those objectives will be disclosed in the corporate governance report within the company’s annual report. This policy is scheduled to take effect on October 28, 2025.